Charting FX: EUR/USD waiting a downside breakout, before going short: IG UK

IG UK

Published on 29 Jun 2016

29 June 2016: IG technical analyst Joshua Mahony talks about the big Brexit trade, the pound, the euro and the safe haven yen. GBP/USD looks like it is forming a double top, while waiting for confirmation there, Josh is also looking at EUR/USD and USD/JPY.

#España - Titulares Noticias 14.30 h. (29/06/2016): Radio Televisión de Castilla y León

Radio Televisión de Castilla y León

Published on 29 Jun 2016

Titulares Noticias 14.30 h. (29/06/2016)

Buenos días Castilla y León (Miércoles 29/06/2016)

Published on 29 Jun 2016

Buenos días Castilla y León (Miércoles 29/06/2016)

Ayer 

#Ireland - Brexit vote: demands for Irish passports skyrocket causing Ireland to ask Britons to stop applying: FRANCE 24 English

FRANCE 24 English

Published on 29 Jun 2016
Brexit vote: demands for Irish passports skyrocket causing Ireland to ask Britons to stop applying

Turkey-Russia relations: Kremlin says it will take time to mend ties with Turkey:

FRANCE 24 English

Published on 29 Jun 2016

Turkish Prime Minister Binali Yildirim spoke about Turkey's relations with Russia: "we will increase the number of friends we have and reduce the number of enemies;"

European leaders gather to discuss next step after Brexit: CNN

CNN

Published on 29 Jun 2016

European head's of state and government officials gather in Brussels to discuss the next steps after the Brexit vote. CNN's Erin McLaughlin reports.

Faron Pharmaceuticals (LON:FARN) drug 'tremendous potential' following Korea deal, says CEO: ProactiveInvestors Stocktube

ProactiveInvestors Stocktube

Published on 29 Jun 2016

Faron Pharmaceuticals drug has ‘tremendous potential’ following Korea deal, says CEO
Finland-based clinical stage drug discovery company Faron Pharmaceuticals (LON:FARN) says there is “tremendous expansion potential” following the latest licensing deal with a Korean pharmaceuticals firm.
The group’s treatment for Acute Respiratory Distress Syndrome, Traumakine is on track to be the very first pharmacological treatment for this serious condition, explains chief executive Markku Jalkanen.

“The disease is very deadly, death usually occurs in 30-45% of patients,” says Jalkanen. The treatment is already in phase III trials in Europe and licenses have been picked up by three companies in Asia, including the deal with Korean firm Pharmbio.

Speaking of the potential licenses in its three major areas, including immunotherapy, chronic infection and vaccination, Jalkanen says that “if successful they will last for twenty years from now, so it’s a long term business opportunity for anyone utilising these technologies.”

http://www.faronpharmaceuticals.com/
 http://www.4-traders.com/FARON-PHARMACEUTICALS-OY-24949011/

#Turkey - Was ISIS behind the Instanbul airport attack: Fox Business

Fox Business

Published on 28 Jun 2016

Former Department of Homeland Security Consultant Mustafa Tameez and American Islamic Forum for Democracy Dr. Zuhdi Jasser on the Instanbul airport attack.

Brexit and the pound: winners and losers | FT Markets: Financial Times

Financial Times

Published on 29 Jun 2016

The pound has fallen more than 12 per cent since the Brexit referendum. While that’s bad news for many, it’s also beneficial for some. The FT's currencies correspondent Roger Blitz gives a guide to the winners and losers from sterling’s fall.